ChipCare Corp, a Toronto-based developer of a handheld cell analyzer for medical testing, has secured $2.05 million in venture capital funding. Investors include Maple Leaf Angels, MaRS Innovation and the University of Toronto, as well as Grand Challenges Canada and the Canadian government.
